Market growth is largely driven by factors such as the advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures performed across the globe. On the other hand, the uncertain regulatory framework in the medical device industry is a major factor restraining the growth of this market.
According to research report the global minimally invasive surgical instruments market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682
Handheld instruments accounted for the largest share of the global MIS instruments market in 2018.
Based on product, the MIS instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, and other instruments. Handheld instruments accounted for the largest share of the MIS instruments market in 2018, owing to factors such as the increasing number of surgical procedures and the development of high-dexterity, low-cost articulating laparoscopic handheld surgical instruments.
By type of surgery, the cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018.
Based on type of surgery, the global MIS instruments market is divided into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries. The cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018. The large share of this segment can be attributed to the rising prevalence of cardiac diseases, growing awareness about the benefits of early detection of cardiovascular complications, the growing number of coronary and percutaneous cardiology interventions, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.
The major players in the Minimally Invasive Surgical instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US). These players have adopted various growth strategies such as product launches, acquisitions, agreements, partnerships & collaborations, and expansions to increase their presence in the global Minimally Invasive Surgical instruments market.
Medtronic (Ireland) dominated the global MIS instruments market in 2018. The company focuses on product commercialization and R&D activities to maintain its leading position in the market. The key products offered by the company include handheld instruments such as surgical stapling devices, retractors, dissectors, trocars, vessel-sealing instruments, hernia mechanical devices, and electrosurgical instruments.
Johnson & Johnson (US) held the second position in the market in 2018. The company operates in the Minimally Invasive Surgical instruments market through its subsidiaries, Ethicon, Inc. and DePuy Synthes. The company focuses on various organic and inorganic growth strategies to gain a competitive edge in the market. In the past three years, the company has launched various surgical staplers and cutting devices in order to add specific products to its portfolio for spine surgeries.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=682
In 2018, North America accounted for the largest share of the global Minimally Invasive Surgical Instruments Market, followed by Europe. The large share of the North American market can be attributed to the large volume of surgical procedures performed in North American countries due to early diagnosis and treatment, high cost of procedures as compared to developing regions, increasing number of surgical centers, and growing adoption of minimally invasive surgical techniques.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to themarket by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062